Pay in installments of $5.62 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
De Eerste en de LaatsteVrees niet; Ik ben de Eerste en Laatste. Zo klonken de woorden van de Heere Jezus Christus tot de balling Johannes op Patmos. Ook in de eindtijd, en de eindstrijd, bewaart Christus de Zijnen. Tegelijk wordt zichtbaar dat alle macht en kracht van satan, de oude slang, verbroken wordt. Staande op het zand van de zee mocht Johannes en mag de bruidskerk van Christus vandaag met hem uitzien naar de komst van de Bruidegom. Soms vrezend en bevend vanwege de
‘Vrees niet; Ik ben de Eerste en Laatste.’ Zo klonken de woorden van de Heere Jezus Christus tot de balling Johannes op Patmos. Ook in de eindtijd, en de eindstrijd, bewaart Christus de Zijnen. Tegelijk wordt zichtbaar dat alle macht en kracht van satan, de oude slang, verbroken wordt. Staande op het zand van de zee mocht Johannes - en mag de bruidskerk van Christus vandaag met hem - uitzien naar de komst van de Bruidegom. Soms vrezend en bevend vanwege de ontzaglijke wereldgerichten, soms ook met opgestoken hoofd omdat de verlossing nabij is. ‘En God Zelf zal bij hen en hun God zijn.’In dit dagboek komen met name de minder bekende hoofdstukken 4 tot en met 22 uit de Openbaring aan Johannes aan de orde. Niet alleen wordt een korte uitleg gegeven, maar ook een voorzichtige duiding van wat de Heere openbaarde in dit laatste Bijbelboek.
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.1 ★★★★★
Based on 28 reviews
Sort
Product Reviews
★★★★★ 5
Latex allergy stopped me from taking bromelain
I was excited to find a natural solution to inflammation and sinus issues. However, after taking this for less than a week, I had a nosebleed that wouldn't stop. After a deep dive on Google, I found out that if you are allergic to latex, you shouldn't take bromelain. Latex Cross-Reactivity: Bromelain is derived from pineapple. People with a latex allergy are at higher risk of an allergic reaction to bromelain. This allergy can manifest as sneezing, itchy throat, or inflammation in the sinuses, which can trigger nosebleeds. I was taking this to get rid of the inflammation in my sinuses, not add to it. I also had tingling in my fingers, which a deep dive on Google said could happen if I am sensitive to quercetin. Quercetin Side Effects: While generally safe, high-dose or sensitive use of quercetin can cause "tingling in the extremities" (numbness/tingling in hands/feet). Thus is neither a high dose of eother of these, nor was it used long-term, so I guess I am sensitive to them both. Beware if you are sensitive to medications and/or have a latex allergy. I can't say if these pills made a positive impact on me, because I only found negative effects, but that is due to my body being so quirky.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 29, 2026
★★★★★ 5
Good
Love this product, take it daily
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 30, 2026
★★★★★ 5
Worth the money
It the first thing I drink in the morning
Taste is good, easy to use, keeps my body happy.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 6, 2026
★★★★★ 5
Metamucil with a fiz!
Great product. Does what it’s supposed to do.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 9, 2026
★★★★★ 5
Competitive pricing
Works as advertised
Name brand item
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 5, 2026